Jeffrey Wiezorek is VP at Kite Pharma, Inc. (KITE). They have made 25 open-market trades across 1 company since 2014, most recently 2017-10-03.
CIK 0001510580
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases totalling $68K since 2014, against 25 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KITE | 11,150 | $2.0M |
Shares reported on the most recent Form 4, priced at the 2017-10-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KITE | SELL | 2017-09-25 | 2017-09-27 | $179.66 | $1.9M | N/A | N/A | N/A |
| KITE | SELL | 2017-07-03 | 2017-07-06 | $104.32 | $1.0M | -0.7% | +9.2% | N/A |
| KITE | SELL | 2017-07-03 | 2017-07-06 | $104.32 | $1.0M | -0.7% | +9.2% | N/A |
| KITE | SELL | 2017-03-01 | 2017-03-02 | $75.01 | $1.4M | +13.2% | +5.5% | -2.4% |
| KITE | SELL | 2017-02-01 | 2017-02-06 | $51.21 | $77K | +1.4% | +41.1% | +32.2% |
| KITE | SELL | 2017-01-06 | 2017-01-10 | $50.00 | $75K | -10.5% | +2.9% | +54.0% |
| KITE | SELL | 2016-12-20 | 2016-12-22 | $50.86 | $36K | +8.3% | +0.0% | +66.4% |
| KITE | SELL | 2016-12-01 | 2016-12-05 | $50.76 | $76K | -8.0% | -8.5% | +38.1% |
| KITE | SELL | 2016-12-01 | 2016-12-05 | $50.68 | $66K | -8.0% | -8.5% | +38.1% |
| KITE | SELL | 2016-11-10 | 2016-11-14 | $50.18 | $75K | -3.2% | -8.8% | +3.3% |
| KITE | SELL | 2016-10-03 | 2016-10-05 | $54.81 | $82K | -11.6% | -23.7% | -17.9% |
| KITE | SELL | 2016-10-03 | 2016-10-05 | $54.72 | $73K | -11.6% | -23.7% | -17.9% |
| KITE | SELL | 2016-09-01 | 2016-09-02 | $58.17 | $72K | -6.2% | -6.6% | -14.0% |
| KITE | SELL | 2016-09-01 | 2016-09-02 | $58.24 | $87K | -6.2% | -6.6% | -14.0% |
| KITE | SELL | 2016-08-01 | 2016-08-02 | $56.66 | $50K | +8.0% | +5.7% | -20.5% |
| KITE | SELL | 2016-08-01 | 2016-08-02 | $56.90 | $85K | +8.0% | +5.7% | -20.5% |
| KITE | SELL | 2016-07-01 | 2016-07-05 | $50.00 | $75K | -4.0% | +15.2% | +8.7% |
| KITE | SELL | 2016-06-01 | 2016-06-02 | $51.22 | $68K | -7.1% | -5.5% | +5.9% |
| KITE | SELL | 2016-05-31 | 2016-06-02 | $50.65 | $152K | -7.1% | -5.5% | +5.9% |
| KITE | SELL | 2016-03-15 | 2016-03-17 | $44.88 | $404K | -1.5% | +6.8% | +17.1% |
| KITE | SELL | 2016-03-15 | 2016-03-17 | $44.70 | $370K | -1.5% | +6.8% | +17.1% |
| KITE | SELL | 2016-02-16 | 2016-02-18 | $44.07 | $397K | +10.0% | -1.5% | -2.1% |
| KITE | SELL | 2016-02-16 | 2016-02-18 | $44.47 | $62K | +10.0% | -1.5% | -2.1% |
| KITE | SELL | 2016-01-15 | 2016-01-19 | $55.26 | $497K | -11.8% | -13.3% | -11.0% |
| KITE | SELL | 2016-01-15 | 2016-01-19 | $55.30 | $393K | -11.8% | -13.3% | -11.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.